Guido Luzzatto

1.1k total citations
47 papers, 797 citations indexed

About

Guido Luzzatto is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Guido Luzzatto has authored 47 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 9 papers in Surgery and 8 papers in Genetics. Recurrent topics in Guido Luzzatto's work include Platelet Disorders and Treatments (19 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Guido Luzzatto is often cited by papers focused on Platelet Disorders and Treatments (19 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Venous Thromboembolism Diagnosis and Management (8 papers). Guido Luzzatto collaborates with scholars based in Italy, United States and Switzerland. Guido Luzzatto's co-authors include Antonio Girolami, Maria Luigia Randi, Giuseppe Cella, Fabrizio Fabris, Fabrizio Fabris, Raffaella Scandellari, Bruno Girolami, Elisabetta Ruzzon, F. Fabris and A Girolami and has published in prestigious journals such as Blood, British Journal of Haematology and Thrombosis and Haemostasis.

In The Last Decade

Guido Luzzatto

46 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Luzzatto Italy 14 453 255 204 114 113 47 797
F. Fabris Italy 16 490 1.1× 161 0.6× 117 0.6× 178 1.6× 73 0.6× 58 767
Derek J. King United Kingdom 11 220 0.5× 333 1.3× 227 1.1× 46 0.4× 96 0.8× 26 762
CJ Carter Canada 10 448 1.0× 211 0.8× 274 1.3× 74 0.6× 261 2.3× 21 851
Jan J. Veltkamp Netherlands 14 735 1.6× 144 0.6× 253 1.2× 200 1.8× 133 1.2× 22 1.1k
Irma O. Szymanski United States 16 335 0.7× 201 0.8× 56 0.3× 92 0.8× 94 0.8× 39 925
Renate Thalhammer Austria 14 393 0.9× 95 0.4× 131 0.6× 199 1.7× 196 1.7× 35 1.0k
M. Blombäck Sweden 18 552 1.2× 133 0.5× 168 0.8× 102 0.9× 185 1.6× 46 1.0k
Chika Uotani Japan 18 363 0.8× 156 0.6× 188 0.9× 67 0.6× 201 1.8× 45 749
Nilsson Im Sweden 19 652 1.4× 235 0.9× 259 1.3× 152 1.3× 158 1.4× 57 1.2k
Hiroshi Jokaji Japan 17 334 0.7× 122 0.5× 173 0.8× 63 0.6× 212 1.9× 36 703

Countries citing papers authored by Guido Luzzatto

Since Specialization
Citations

This map shows the geographic impact of Guido Luzzatto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Luzzatto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Luzzatto more than expected).

Fields of papers citing papers by Guido Luzzatto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Luzzatto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Luzzatto. The network helps show where Guido Luzzatto may publish in the future.

Co-authorship network of co-authors of Guido Luzzatto

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Luzzatto. A scholar is included among the top collaborators of Guido Luzzatto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Luzzatto. Guido Luzzatto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fabris, F., et al.. (2002). Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia. Journal of Internal Medicine. 252(2). 149–154. 50 indexed citations
2.
Luzzatto, Guido, et al.. (2000). Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases.. PubMed. 85(8). 888–90. 4 indexed citations
3.
Fabris, F., et al.. (2000). Clinical and laboratory factors that affect the post-transfusion platelet increment. Transfusion Science. 23(1). 63–68. 20 indexed citations
4.
Luzzatto, Guido, et al.. (1998). Platelet Count, Anti-Heparin/Platelet Factor 4 Antibodies and Tissue Factor Pathway Inhibitor Plasma Antigen Level in Chronic Dialysis. Thrombosis Research. 89(3). 115–122. 51 indexed citations
5.
Cella, Giuseppe, Roberto Vettor, C. Macor, et al.. (1997). Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (TFPI) Antigen in Severe Nondiabetic Obese Patients: Effect of Hyperinsulinemia. Seminars in Thrombosis and Hemostasis. 23(2). 129–134. 5 indexed citations
6.
Fabris, Fabrizio, et al.. (1997). Heparin-Induced Thrombocytopenia: Prevalence in a Large Cohort of Patients and Confirmed Role of PF4/Heparin Complex as the Main Antigen for Antibodies. Clinical and Applied Thrombosis/Hemostasis. 3(3). 203–209. 5 indexed citations
7.
Cella, Giuseppe, et al.. (1997). Tissue Factor Pathway Inhibitor (TFPI) Antigen Plasma Level in Patients with Interstitial Lung Disease Before and After Heparin Administration. Seminars in Thrombosis and Hemostasis. 23(1). 45–49. 6 indexed citations
8.
Fabris, Fabrizio, et al.. (1995). Heparin-induced thrombocytopenia - prevalence in 236 patients and evidence that complex pf4 - heparin is the main antigen for the antibodies. Thrombosis and Haemostasis. 73(6). 982–982. 2 indexed citations
9.
Luzzatto, Guido, et al.. (1995). [Symptomatic relief of carcinoid syndrome by ketanserin. A case].. PubMed. 24(19). 897–9. 1 indexed citations
10.
Randi, Maria Luigia, et al.. (1993). Haemolytic uraemic syndrome during treatment with ketorolac trometamol.. BMJ. 306(6871). 186.3–186. 5 indexed citations
11.
Luzzatto, Guido, et al.. (1993). Lack of increase or reduction in circulating platelet factor 4 and heparin-releasable platelet factor 4 in symptomatic patients with asthma.. PubMed. 7(2). 151–4. 8 indexed citations
12.
13.
Luzzatto, Guido, Michael H. Kroll, George B. Zavoico, & Andrew I. Schafer. (1991). Regulation of the phosphoinositide cycle by Na+/H+ exchange and intracellular pH in human platelets. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1084(1). 78–86. 11 indexed citations
14.
Luzzatto, Guido, et al.. (1989). Effects of Glycosaminoglycans and Protamine Chloridrate on Platelet Aggregation Induced by Collagen and Thrombin. Angiology. 40(3). 170–174. 7 indexed citations
15.
Girolami, Antonio, et al.. (1988). The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disorders.. PubMed. 115(6). 825–32. 4 indexed citations
16.
Luzzatto, Guido, et al.. (1987). Failure of Two Anti-Platelet Drugs (Indobufen and Dipyridamole) to Improve Thrombocytopenia in Liver Cirrhosis. Acta Haematologica. 77(2). 101–106. 5 indexed citations
17.
Luzzatto, Guido, et al.. (1987). Thrombocytopenia in liver cirrhosis complicated by variceal haemorrhage: lack of increase in platelet count after spleno renal distal shunt.. PubMed. 114(1). 145–52. 2 indexed citations
18.
Cella, Giuseppe, et al.. (1986). Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.. PubMed. 17(5-6). 331–46. 5 indexed citations
19.
Girolami, Antonio, et al.. (1983). A family with heterozygous factor X friuli defect outside friuli. Annals of Hematology. 46(3). 149–154. 11 indexed citations
20.
Girolami, Antonio, et al.. (1983). A new family with classical factor X deficiency as demonstrated by electroimmunoassay. Annals of Hematology. 47(1). 53–57. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Fabris Breakdown of academic impact, for papers by Derek J. King Breakdown of academic impact, for papers by CJ Carter Breakdown of academic impact, for papers by Jan J. Veltkamp Breakdown of academic impact, for papers by Irma O. Szymanski Breakdown of academic impact, for papers by Renate Thalhammer Breakdown of academic impact, for papers by M. Blombäck Breakdown of academic impact, for papers by Chika Uotani Breakdown of academic impact, for papers by Nilsson Im Breakdown of academic impact, for papers by Hiroshi Jokaji
Rankless by CCL
2026